Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Columbia Sportswear President Peter J. Bragdon Sells $26.6K of Stock
Peter J. Bragdon, President, sold 375 shares of Columbia Sportswear Co at $70.81 a share, worth $26.6K in total on Nov 2, 2026. Shares held after the trade: 28,950 (-1.3%).
Duolingo Insider William B. Gordon Sells $1.36M of Stock
William B. Gordon sold 10,000 shares of Duolingo, Inc. at $132.14 to $139.20 a share (average $136.38) in 8 transactions, worth $1.36M in total on Nov 2, 2026. Shares held after the trade: 58,415 (-1.2%).
Tango Therapeutics President, R&D Adam Crystal Sells $112K of Stock
Adam Crystal, President, R&D, sold 5,000 shares of Tango Therapeutics, Inc. at $22.26 to $22.99 a share (average $22.42) in 2 transactions, worth $112K in total on Nov 2, 2026. Shares held after the trade: 115,743 (-0.9%).
Tango Therapeutics Principal Accounting Officer Jessica Newcomb Sells $158K of Stock
Jessica Newcomb, Principal Accounting Officer, sold 7,031 shares of Tango Therapeutics, Inc. at $22.28 to $22.98 a share (average $22.42) in 2 transactions, worth $158K in total on Nov 2, 2026. Shares held after the trade: 52,090 (-2.7%).
Old National Bancorp CFO John V. Moran Sells $493K of Stock
John V. Moran, CFO, sold 19,261 shares of Old National Bancorp at $25.57 a share, worth $493K in total on Nov 3, 2026. Shares held after the trade: 101,467 (-16.0%).
Corcept Therapeutics Insider Sean Maduck Sells $2.05M of Stock
Sean Maduck sold 25,000 shares of Corcept Therapeutics Inc at $81.42 to $82.68 a share (average $81.85) in 3 transactions, worth $2.05M in total between Nov 2, 2026 and Nov 3, 2026. Shares held after the trade: 9,938 (-31.4%).
Snowflake EVP, Product Management Christian Kleinerman Sells $3.06M of Stock
Christian Kleinerman, EVP, Product Management, sold 10,000 shares of Snowflake Inc. at $306.01 a share, worth $3.06M in total on Nov 2, 2026. Shares held after the trade: 303,738 (-3.2%).
Roberto Wandenkolk Vieira, President, Oncology, sold 8,333 shares of Corcept Therapeutics Inc at $80.73 to $81.52 a share (average $80.89) in 2 transactions, worth $674K in total on Nov 2, 2026. Shares held after the trade: 3,946 (-29.8%).
Personalis presented interim Victory study data for NeXT Personal, demonstrating 96% pre-surgical sensitivity and 100% detection of colorectal cancer recurrences with significant lead-time advantages.
Accel Entertainment President and CEO Mark T. Phelan Sells $300K of Stock
Mark T. Phelan, President and CEO, sold 25,000 shares of Accel Entertainment, Inc. at $12.00 a share, worth $300K in total on Nov 2, 2026. Shares held after the trade: 216,464 (-10.4%).
Tenable Holdings Insider A. Brooke Seawell Sells $1.49M of Stock
A. Brooke Seawell sold 30,000 shares of Tenable Holdings, Inc. at $48.73 to $50.33 a share (average $49.53) in 2 transactions, worth $1.49M in total on Nov 2, 2026. Shares held after the trade: 0 (-100.0%).
Tenable Holdings Insider Barron Anschutz Sells $510K of Stock
Barron Anschutz sold 10,000 shares of Tenable Holdings, Inc. at $51.00 a share, worth $510K in total on Nov 2, 2026. Shares held after the trade: 66,077 (-13.1%).
Republic Services EVP, Chief Development Officer Brian A. Bales Sells $830K of Stock
Brian A. Bales, EVP, Chief Development Officer, sold 3,400 shares of Republic Services, Inc. at $244.00 a share, worth $830K in total on Nov 2, 2026. Shares held after the trade: 17,616 (-16.2%).
MercadoLibre is prioritizing ecosystem engagement and market share over short-term margins, leveraging high-growth credit and advertising segments to fund aggressive logistics and AI investments.
Franklin Covey delivered fiscal 2026 results within guidance, pivoting to a high-leverage subscription model with strong North American deferred revenue growth of 17% setting a foundation for fiscal 2027 acceleration.
CAVA delivered 22.1% revenue growth and reached 500 restaurants, though margins faced pressure from labor investments and third-party delivery mix despite positive traffic and strong new unit productivity.
STAAR Surgical delivered record nine-month revenue driven by a structural shift from lasers to lenses, though supply constraints in China and temporary margin pressures from ERP implementation impacted the quarter.
Caris Life Sciences delivered record Q3 2026 revenue of $275.4M, up 27%, while raising full-year guidance and expanding its oncology platform into monitoring and MRD markets.
Figma delivered a strong Q3 beat with 43% revenue growth, driven by AI monetization and high net dollar retention, while aggressively investing in first-party models and its 'full stack canvas' strategy.
Aspen Neuroscience Insider Peter A. Thompson Buys $15M of Stock
Peter A. Thompson bought 1,000,000 shares of Aspen Neuroscience, Inc. at $15.00 a share, worth $15M in total on Nov 2, 2026. Shares held after the trade: 3,589,132 (+38.6%).
Aspen Neuroscience Insider Orbimed Advisors LLC Buys $15M of Stock
Orbimed Advisors LLC bought 1,000,000 shares of Aspen Neuroscience, Inc. at $15.00 a share, worth $15M in total on Nov 2, 2026. Shares held after the trade: 3,589,132 (+38.6%).
TKO delivered a strong beat-and-raise quarter driven by record UFC performance and accelerating WWE partnership revenue despite event timing headwinds.
Joby Aviation is transitioning from development to early operations, leveraging a strong $2.2 billion balance sheet and the strategic acquisition of Resonance Sciences to scale defense and autonomy.
Rubrik CTO Arvind Nithrakashyap Sells $4.51M of Stock
Arvind Nithrakashyap, CTO, sold 38,460 shares of Rubrik, Inc. at $114.17 to $122.42 a share (average $117.39) in 21 transactions, worth $4.51M in total between Nov 2, 2026 and Nov 4, 2026. Shares held after the trade: 272,538 (-0.1%).
Arcutis Biotherapeutics EVP, CLO Masaru Matsuda Sells $1.41M of Stock
Masaru Matsuda, EVP, CLO, sold 41,219 shares of Arcutis Biotherapeutics, Inc. at $31.86 to $34.32 a share (average $34.24) in 2 transactions, worth $1.41M in total between Nov 2, 2026 and Nov 4, 2026. Shares held after the trade: 111,289 (-26.4%).
Arcutis Biotherapeutics EVP, CMO Patrick Burnett Sells $30K of Stock
Patrick Burnett, EVP, CMO, sold 943 shares of Arcutis Biotherapeutics, Inc. at $31.86 a share, worth $30K in total on Nov 2, 2026. Shares held after the trade: 116,649 (-0.8%).
Arcutis Biotherapeutics Insider Todd Watanabe Sells $139K of Stock
Todd Watanabe sold 4,377 shares of Arcutis Biotherapeutics, Inc. at $31.86 a share, worth $139K in total on Nov 2, 2026. Shares held after the trade: 712,826 (-0.6%).
Meta Platforms COO Javier Olivan Sells $967K of Stock
Javier Olivan, COO, sold 1,575 shares of Meta Platforms, Inc. at $614.15 a share, worth $967K in total on Nov 2, 2026. Shares held after the trade: 74,989 (-0.5%).
Jazz Pharmaceuticals Insider Bruce C. Cozadd Sells $1.3M of Stock
Bruce C. Cozadd sold 6,000 shares of Jazz Pharmaceuticals plc at $215.84 a share, worth $1.3M in total on Nov 2, 2026. Shares held after the trade: 339,875 (-1.7%).
Veracyte delivered a Q3 revenue beat but significantly lowered Decipher prostate volume expectations, signaling a transition from outsized guideline-driven growth to a normalized, more competitive market environment.